Airway Epithelium Gene Expression in the Diagnosis of Lung Cancer: AEGIS CLIA

Summary

The primary objective of this study is to substantiate prediction accuracy(with a tighter 95% confidence interval compared to current diagnostic modalities), of a lung cancer biomarker for risk stratification of patients into high and low risk categories to aid in clinical evaluation of the patient.

Conditions

• Lung Cancer

Sponsors & Collaborators

• Beth Israel Deaconess Medical Center

  collaborator OTHER

• Columbia University

  collaborator OTHER

• Vanderbilt University

  collaborator OTHER

• University of British Columbia

  collaborator OTHER

• University of Pennsylvania

  collaborator OTHER

• New York University

  collaborator OTHER

• Temple University

  collaborator OTHER

• Indiana University

  collaborator OTHER

• University of Alabama at Birmingham

  collaborator OTHER

• University of Virginia

  collaborator OTHER

• University of Missouri-Columbia

  collaborator OTHER

• Louisiana State University Health Sciences Center in New Orleans

  collaborator OTHER

• University of Dublin, Trinity College

  collaborator OTHER

• Georgia Lung Associates PC

  collaborator OTHER

• Allegro Diagnostics, Corp.

  lead INDUSTRY

Principal Investigators

• Duncan Whitney, PhD · Allegro Diagnostics

Eligibility

Min Age

21 Years

Sex

ALL

Healthy Volunteers

No

Timeline & Regulatory

Start

2009-01-31

Primary Completion

2013-05-31

Completion

2013-05-31

Countries

• United States
• Canada
• Ireland

Study Locations